Avalyn Pharma Inc. ($AVLN)
Filing Information
| Accession Number | 0001193125-26-201887 |
|---|---|
| Form Type | 4 |
| Filing Date | May 1, 2026 |
| Document | View SEC Filing |
Transactions
10
Total Shares
56,282,918
Total Value
$9,999,990.00
P&L
+52.4% (+$5,238,883.65)
Transactions
| Name | Title | Security | Derivative | Transaction Date | Type | Shares | Price | Total Cost | Shares After | Direct/Indirect | Nature of Ownership | Actions |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
10% Owner | Common Stock | โ | May 1, 2026 | Conversion | 1,419,298 | โ | โ | 1,419,298 | Indirect | See Note 2 | View Details | |
10% Owner | Common Stock | โ | May 1, 2026 | Conversion | 489,486 | โ | โ | 1,908,784 | Indirect | See Note 2 | View Details | |
10% Owner | Common Stock | โ | May 1, 2026 | Purchase | 277,778 | $18.00 | $5,000,004.00 | 2,186,562 | Indirect | See Note 2 | View Details | |
10% Owner | Common Stock | โ | May 1, 2026 | Conversion | 354,824 | โ | โ | 354,824 | Indirect | See Note 4 | View Details | |
10% Owner | Common Stock | โ | May 1, 2026 | Conversion | 489,486 | โ | โ | 844,310 | Indirect | See Note 4 | View Details | |
10% Owner | Common Stock | โ | May 1, 2026 | Purchase | 277,777 | $18.00 | $4,999,986.00 | 1,122,087 | Indirect | See Note 4 | View Details | |
10% Owner | Series C-1 Convertible Preferred Stock | Derivative | May 1, 2026 | Conversion | 27,309,719 | โ | โ | 0 | Indirect | See Note 2 | View Details | |
10% Owner | Series D Convertible Preferred Stock | Derivative | May 1, 2026 | Conversion | 9,418,561 | โ | โ | 0 | Indirect | See Note 2 | View Details | |
10% Owner | Series C-1 Convertible Preferred Stock | Derivative | May 1, 2026 | Conversion | 6,827,429 | โ | โ | 0 | Indirect | See Note 4 | View Details | |
10% Owner | Series D Convertible Preferred Stock | Derivative | May 1, 2026 | Conversion | 9,418,560 | โ | โ | 0 | Indirect | See Note 4 | View Details |